Another prominent fighter from UFC 200 has failed a drug test.
On Friday, the UFC released a statement that heavyweight Brock Lesnar had been notified of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collected on June 28. According to the statement, the results were received from the WADA-accredited UCLA Olympic Analytical Lab on July 14, five days after the conclusion of UFC 200. The substance for which Lesnar tested postive was not revealed.
"USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case, the statement read. “It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed in close proximity to Lesnar’s bout at UFC 200 in Las Vegas.
"Consistent with all previous potential anti-doping violations, additional information will be provided at the appropriate time as the process moves forward."
In his first MMA bout in nearly five years, Lesnar defeated Mark Hunt via unanimous decision in the co-main event of UFC 200 on July 9. Prior to the fight, Lesnar laughed off his opponent’s accusations that he was “juiced to the gills.”
"I've been dealing with that my entire life," Lesnar said during a media call to promote UFC 200. "I'm a white boy and I'm jacked -- deal with it. What do you want me to say? I'm a white boy and I'm jacked. Deal with it."
Lesnar, who initially retired from MMA following a loss to Alistair Overeem at UFC 141 in December 2011, received an exemption from USADA waiving the four-month notice that is normally required of an athlete coming out of retirement. Exemptions can be granted “in exceptional circumstances or where the strict application of that rule would be manifestly unfair to an athlete.” However, the massive heavyweight was subject to both in- and out-of-competition drug testing leading up to UFC 200.
Lesnar remains under contract with World Wrestling Entertainment and is scheduled to appear at SummerSlam in August. However, following his win over Hunt, he left the door open to compete in the Octagon again. The South Dakota native would be facing a two-year suspension if his appeal is unsuccessful, making another UFC bout unlikely.
Lesnar’s failed test was the second drug test-related bombshell surrounding the promotion’s bicentennial event. Just days before UFC 200, Jon Jones was pulled from the headliner against Daniel Cormier when it was revealed he tested positive for a banned substance in an out-of-competition screening on June 16. Jones is rumored to have tested positive for estrogen blockers, but the nature of his test has not been revealed. Like Lesnar, Jones could be facing a two-year suspension.